The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Bleeding in STEMI with staged multivessel PCI: is it truly benign?

EuroIntervention 2016;12:1203-1205. DOI: 10.4244/EIJV12I10A198

Division of Cardiology, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada

“If you prick us do we not bleed?” – William Shakespeare

Remarkable progress has been made over the last decade with strategies employed to mitigate bleeding in ST-elevation myocardial infarction (STEMI). Still, with advances in more potent pharmacotherapy and developments in sophisticated percutaneous coronary intervention (PCI) techniques (e.g., controlled antegrade and retrograde subintimal tracking/dissection re-entry for chronic total occlusion), bleeding remains a concern1. In recent years, this has become an integral focus in STEMI care, given the association between periprocedural bleeds and survival2,3. Moreover, haemorrhagic complications can lead to longer hospital stay (subjecting patients to nosocomial infection), ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Announcing a new EAPCI fellowship programme for 2017